These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26302093)

  • 1. Effect of Selective Mineralocorticoid Receptor Blockade on Flow-Mediated Dilation and Insulin Resistance in Older Adults with Metabolic Syndrome.
    Hwang MH; Yoo JK; Luttrell M; Meade TH; English M; Christou DD
    Metab Syndr Relat Disord; 2015 Oct; 13(8):356-61. PubMed ID: 26302093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effect of mineralocorticoid receptor antagonism on vascular function in healthy older adults.
    Hwang MH; Yoo JK; Luttrell M; Kim HK; Meade TH; English M; Talcott S; Jaffe IZ; Christou DD
    Exp Gerontol; 2016 Jan; 73():86-94. PubMed ID: 26639352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptors modulate vascular endothelial function in human obesity.
    Hwang MH; Yoo JK; Luttrell M; Kim HK; Meade TH; English M; Segal MS; Christou DD
    Clin Sci (Lond); 2013 Dec; 125(11):513-20. PubMed ID: 23786536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects.
    Garg R; Kneen L; Williams GH; Adler GK
    Diabetes Obes Metab; 2014 Mar; 16(3):268-72. PubMed ID: 24125483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mineralocorticoid receptors in arterial stiffness in human aging.
    Hwang MH; Yoo JK; Luttrell M; Kim HK; Meade TH; English M; Nichols WW; Christou DD
    Exp Gerontol; 2013 Aug; 48(8):701-4. PubMed ID: 23707930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate improves vascular endothelial function by reducing oxidative stress while increasing endothelial nitric oxide synthase in healthy normolipidemic older adults.
    Walker AE; Kaplon RE; Lucking SM; Russell-Nowlan MJ; Eckel RH; Seals DR
    Hypertension; 2012 Dec; 60(6):1517-23. PubMed ID: 23108655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular Effects of Eplerenone in Coronary Artery Disease With Preserved Ejection Fraction: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Sudano I; Naegele M; Roas S; Périat D; Frank M; Kouroedov A; Noll G; Lüscher TF; Enseleit F; Ruschitzka F; Flammer AJ
    Clin Cardiol; 2016 May; 39(5):285-90. PubMed ID: 26991772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of aldosterone on diet-induced fatty liver formation in male C57BL/6 mice: comparison of adrenalectomy and mineralocorticoid receptor blocker.
    Gamliel-Lazarovich A; Raz-Pasteur A; Coleman R; Keidar S
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1086-92. PubMed ID: 23524523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low-dose mineralocorticoid receptor antagonists on metabolic profile and endothelial dysfunction in metabolic syndrome.
    Kanchan V; Pawan K; Sudhir V; Harpreet Singh K
    Diabetes Metab; 2016 Feb; 42(1):65-8. PubMed ID: 26563809
    [No Abstract]   [Full Text] [Related]  

  • 11. Mesoglycan improves vascular reactivity and insulin sensitivity in patients with metabolic syndrome.
    Valvano A; Bosso G; Apuzzi V; Riccone F; Saccà L; Oliviero U
    Atherosclerosis; 2015 Dec; 243(2):407-13. PubMed ID: 26520894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation.
    Bavry AA; Handberg EM; Huo T; Lerman A; Quyyumi AA; Shufelt C; Sharaf B; Merz CN; Cooper-DeHoff RM; Sopko G; Pepine CJ
    Am Heart J; 2014 Jun; 167(6):826-32. PubMed ID: 24890531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Trial.
    Nowak KL; Gitomer B; Farmer-Bailey H; Wang W; Malaczewski M; Klawitter J; You Z; George D; Patel N; Jovanovich A; Chonchol M
    Am J Kidney Dis; 2019 Aug; 74(2):213-223. PubMed ID: 30803706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.
    Watts GF; Playford DA; Croft KD; Ward NC; Mori TA; Burke V
    Diabetologia; 2002 Mar; 45(3):420-6. PubMed ID: 11914748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin therapy improves brachial artery endothelial function in nephrotic syndrome.
    Dogra GK; Watts GF; Herrmann S; Thomas MA; Irish AB
    Kidney Int; 2002 Aug; 62(2):550-7. PubMed ID: 12110017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism.
    Luther JM; Gainer JV; Murphey LJ; Yu C; Vaughan DE; Morrow JD; Brown NJ
    Hypertension; 2006 Dec; 48(6):1050-7. PubMed ID: 17043157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin improves endothelial function in patients with metabolic syndrome.
    Vitale C; Mercuro G; Cornoldi A; Fini M; Volterrani M; Rosano GM
    J Intern Med; 2005 Sep; 258(3):250-6. PubMed ID: 16115299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris.
    Rajendra NS; Ireland S; George J; Belch JJ; Lang CC; Struthers AD
    J Am Coll Cardiol; 2011 Aug; 58(8):820-8. PubMed ID: 21835317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Metabolic and Inflammatory Indices in HIV.
    Srinivasa S; Fitch KV; Wong K; O'Malley TK; Maehler P; Branch KL; Looby SE; Burdo TH; Martinez-Salazar EL; Torriani M; Lyons SH; Weiss J; Feldpausch M; Stanley TL; Adler GK; Grinspoon SK
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2376-2384. PubMed ID: 29659888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eplerenone improves vascular function and reduces platelet activation in diabetic rats.
    Schafer A; Vogt C; Fraccarollo D; Widder J; Flierl U; Hildemann SK; Ertl G; Bauersachs J
    J Physiol Pharmacol; 2010 Feb; 61(1):45-52. PubMed ID: 20228414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.